RU2007118385A - Контрастные агенты для направлений доставки во внеклеточный матрикс - Google Patents
Контрастные агенты для направлений доставки во внеклеточный матрикс Download PDFInfo
- Publication number
- RU2007118385A RU2007118385A RU2007118385/04A RU2007118385A RU2007118385A RU 2007118385 A RU2007118385 A RU 2007118385A RU 2007118385/04 A RU2007118385/04 A RU 2007118385/04A RU 2007118385 A RU2007118385 A RU 2007118385A RU 2007118385 A RU2007118385 A RU 2007118385A
- Authority
- RU
- Russia
- Prior art keywords
- contrast agent
- agent according
- formula
- amino acid
- acid
- Prior art date
Links
- 239000002872 contrast media Substances 0.000 title claims abstract 29
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 title 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 title 1
- 210000002744 extracellular matrix Anatomy 0.000 title 1
- 241001465754 Metazoa Species 0.000 claims abstract 3
- 102000008186 Collagen Human genes 0.000 claims abstract 2
- 108010035532 Collagen Proteins 0.000 claims abstract 2
- 230000015572 biosynthetic process Effects 0.000 claims abstract 2
- 229920001436 collagen Polymers 0.000 claims abstract 2
- 238000011503 in vivo imaging Methods 0.000 claims abstract 2
- 125000005647 linker group Chemical group 0.000 claims abstract 2
- 125000000539 amino acid group Chemical group 0.000 claims 7
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 3
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical group OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 3
- 239000004472 Lysine Substances 0.000 claims 3
- 235000003704 aspartic acid Nutrition 0.000 claims 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 3
- 239000002738 chelating agent Substances 0.000 claims 3
- 235000018417 cysteine Nutrition 0.000 claims 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 3
- 235000018977 lysine Nutrition 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 239000004475 Arginine Substances 0.000 claims 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 2
- 239000003638 chemical reducing agent Substances 0.000 claims 2
- 238000003384 imaging method Methods 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 238000002600 positron emission tomography Methods 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 238000002603 single-photon emission computed tomography Methods 0.000 claims 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
- IYKLZBIWFXPUCS-VIFPVBQESA-N (2s)-2-(naphthalen-1-ylamino)propanoic acid Chemical compound C1=CC=C2C(N[C@@H](C)C(O)=O)=CC=CC2=C1 IYKLZBIWFXPUCS-VIFPVBQESA-N 0.000 claims 1
- BLCJBICVQSYOIF-UHFFFAOYSA-N 2,2-diaminobutanoic acid Chemical compound CCC(N)(N)C(O)=O BLCJBICVQSYOIF-UHFFFAOYSA-N 0.000 claims 1
- GNTIRRQEPHPUCI-UHFFFAOYSA-N 2-[2-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethylamino]-2-oxoethoxy]acetic acid Chemical compound NCCOCCOCCOCCNC(=O)COCC(O)=O GNTIRRQEPHPUCI-UHFFFAOYSA-N 0.000 claims 1
- PECYZEOJVXMISF-UHFFFAOYSA-N 3-aminoalanine Chemical compound [NH3+]CC(N)C([O-])=O PECYZEOJVXMISF-UHFFFAOYSA-N 0.000 claims 1
- 125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 claims 1
- UQTZMGFTRHFAAM-ZETCQYMHSA-N 3-iodo-L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(I)=C1 UQTZMGFTRHFAAM-ZETCQYMHSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N Aspartic acid Chemical compound OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- NTWVQPHTOUKMDI-YFKPBYRVSA-N N-Methyl-arginine Chemical compound CN[C@H](C(O)=O)CCCN=C(N)N NTWVQPHTOUKMDI-YFKPBYRVSA-N 0.000 claims 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 1
- 150000003973 alkyl amines Chemical class 0.000 claims 1
- 125000002877 alkyl aryl group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000001408 amides Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 125000002837 carbocyclic group Chemical group 0.000 claims 1
- 239000013522 chelant Substances 0.000 claims 1
- 125000001142 dicarboxylic acid group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 125000000350 glycoloyl group Chemical group O=C([*])C([H])([H])O[H] 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 238000012634 optical imaging Methods 0.000 claims 1
- 229960003104 ornithine Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 239000012217 radiopharmaceutical Substances 0.000 claims 1
- 229940121896 radiopharmaceutical Drugs 0.000 claims 1
- 230000002799 radiopharmaceutical effect Effects 0.000 claims 1
- 125000006853 reporter group Chemical group 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 125000000542 sulfonic acid group Chemical group 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
- 230000008685 targeting Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20045081 | 2004-11-22 | ||
| NO200745081 | 2004-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2007118385A true RU2007118385A (ru) | 2008-12-27 |
Family
ID=36182407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007118385/04A RU2007118385A (ru) | 2004-11-22 | 2005-11-21 | Контрастные агенты для направлений доставки во внеклеточный матрикс |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8182790B2 (OSRAM) |
| EP (2) | EP2243496A3 (OSRAM) |
| JP (2) | JP5116480B2 (OSRAM) |
| KR (1) | KR20070091609A (OSRAM) |
| CN (1) | CN101107016B (OSRAM) |
| AT (1) | ATE494913T1 (OSRAM) |
| AU (1) | AU2005307195A1 (OSRAM) |
| BR (1) | BRPI0518328A2 (OSRAM) |
| CA (1) | CA2586621A1 (OSRAM) |
| DE (1) | DE602005025911D1 (OSRAM) |
| ES (1) | ES2358745T3 (OSRAM) |
| IL (1) | IL182898A0 (OSRAM) |
| MX (1) | MX2007006050A (OSRAM) |
| NO (1) | NO20073039L (OSRAM) |
| RU (1) | RU2007118385A (OSRAM) |
| WO (1) | WO2006054904A2 (OSRAM) |
| ZA (1) | ZA200705043B (OSRAM) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0610395D0 (en) * | 2006-05-25 | 2006-07-05 | Ge Healthcare Ltd | Novel imaging agents |
| JP2010502585A (ja) * | 2006-08-28 | 2010-01-28 | ジーイー・ヘルスケア・リミテッド | ６８Ｇａ標識ペプチド系放射性医薬品 |
| JP2008266194A (ja) * | 2007-04-19 | 2008-11-06 | Hiroshi Tanaka | 分子プローブの原料として有用な新規有機化合物 |
| GB0722650D0 (en) * | 2007-11-19 | 2007-12-27 | Ge Healthcare Ltd | Novel imaging method |
| US8466258B2 (en) | 2007-12-13 | 2013-06-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis |
| EP2732826B1 (en) | 2008-01-18 | 2017-11-08 | Visen Medical, Inc. | Fluorescent imaging agents |
| KR101430627B1 (ko) | 2008-05-13 | 2014-08-14 | 유니버시티 오브 캔사스 | 금속 추출 펩타이드(ｍａｐ) 태그 및 관련된 방법 |
| GB0814722D0 (en) * | 2008-08-12 | 2008-09-17 | Ge Healthcare Ltd | Treatment monitoring |
| GB0910013D0 (en) * | 2009-06-10 | 2009-07-22 | Ge Healthcare Ltd | PET imaging of fibogenesis |
| KR100991716B1 (ko) * | 2009-10-22 | 2010-11-04 | 경북대학교 산학협력단 | 광학영상 조영제, 그 용도 및 장치 |
| CN102504603B (zh) * | 2011-10-20 | 2014-01-29 | 中国海洋大学 | 一种多聚物与生物染色剂的偶合物及其制备方法和用途 |
| US9187735B2 (en) | 2012-06-01 | 2015-11-17 | University Of Kansas | Metal abstraction peptide with superoxide dismutase activity |
| WO2015085005A1 (en) * | 2013-12-03 | 2015-06-11 | The General Hospital Corporation | Molecular imaging probes |
| CN117623996B (zh) * | 2022-08-10 | 2025-07-22 | 中国药科大学 | 一种二价keap1-nrf2抑制剂、制备方法及其医药用途 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4647447A (en) | 1981-07-24 | 1987-03-03 | Schering Aktiengesellschaft | Diagnostic media |
| US4615876A (en) * | 1983-04-25 | 1986-10-07 | Curators Of The University Of Missouri | Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides |
| US4687659A (en) | 1984-11-13 | 1987-08-18 | Salutar, Inc. | Diamide-DTPA-paramagnetic contrast agents for MR imaging |
| US5268486A (en) | 1986-04-18 | 1993-12-07 | Carnegie-Mellon Unversity | Method for labeling and detecting materials employing arylsulfonate cyanine dyes |
| US6048982A (en) | 1986-04-18 | 2000-04-11 | Carnegie Mellon University | Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
| AU641361B2 (en) | 1988-05-02 | 1993-09-23 | Zynaxis Technologies, Incorporated | Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles |
| GB8903022D0 (en) | 1989-02-10 | 1989-03-30 | Celltech Ltd | Chemical compounds |
| CA2124329C (en) | 1991-11-27 | 2008-11-18 | Gregory A. Kopia | Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| NZ335799A (en) | 1996-10-28 | 2000-11-24 | Nycomed Imaging As | Improvements in or relating to diagnostic/therapeutic agents |
| ES2257771T3 (es) * | 1996-10-28 | 2006-08-01 | Amersham Health As | Agentes de contraste. |
| CA2278200A1 (en) * | 1997-01-29 | 1998-07-30 | Nycomed Imaging As | Polymers |
| EP1037947B1 (en) | 1997-07-28 | 2003-09-10 | Amersham plc | Cyanine dyes |
| US5942637A (en) * | 1998-03-30 | 1999-08-24 | North Dakota State University Research Foundation | Compounds containing tetradecachlorocyclohexasilane dianion |
| US6852318B1 (en) * | 1998-05-08 | 2005-02-08 | The Regents Of The University Of California | Methods for detecting and inhibiting angiogenesis |
| PT1075277E (pt) * | 1998-05-08 | 2009-05-08 | Univ California | Métodos para detectar e inibir a angiogénese |
| JP2000095758A (ja) * | 1998-09-18 | 2000-04-04 | Schering Ag | 近赤外蛍光造影剤および蛍光造影方法 |
| US6230777B1 (en) | 1999-02-04 | 2001-05-15 | Midmac Systems, Inc. | Filter forming and joining apparatus |
| NZ521735A (en) | 2000-04-12 | 2004-12-24 | Amersham Health As | Peptide-based compounds, their use as targeting vectors that bind to receptors associated with antiogenesis such as integrin receptors |
| NO20004795D0 (no) * | 2000-09-26 | 2000-09-26 | Nycomed Imaging As | Peptidbaserte forbindelser |
| CA2429956A1 (en) * | 2000-11-27 | 2002-07-18 | Alan P. Carpenter, Jr. | Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| GB0116815D0 (en) * | 2001-07-10 | 2001-08-29 | Nycomed Amersham Plc | Improved chelator conjugates |
| JP4510444B2 (ja) * | 2001-07-10 | 2010-07-21 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | ペプチドベースの化合物 |
| GB0206750D0 (en) | 2002-03-22 | 2002-05-01 | Amersham Plc | Radiofluorination methods |
| DE60324471D1 (de) | 2002-06-17 | 2008-12-11 | Cartela R & D Ab | Verfahren und verwendungszwecke der integrin alpha 10 kette zur diagnose und nachweis von atherosklerotischer plaquebildung in vitro |
| US7063158B2 (en) | 2003-06-16 | 2006-06-20 | Deepwater Technologies, Inc. | Bottom tensioned offshore oil well production riser |
| NO20033115D0 (no) * | 2003-07-08 | 2003-07-08 | Amersham Health As | Peptid-baserte forbindelser |
| GB0317815D0 (en) * | 2003-07-30 | 2003-09-03 | Amersham Health As | Imaging agents |
| US7371364B2 (en) | 2003-08-15 | 2008-05-13 | Board Of Regents, The University Of Texas System | Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy |
| US7431914B2 (en) * | 2003-11-24 | 2008-10-07 | Ge Healthcare As | Contrast agent |
| JP2007526300A (ja) * | 2004-03-04 | 2007-09-13 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | 医薬化合物 |
| CN1968963A (zh) * | 2004-06-16 | 2007-05-23 | 通用电气医疗集团股份有限公司 | 基于肽的化合物 |
| JP5280682B2 (ja) * | 2004-06-16 | 2013-09-04 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | ペプチド系化合物 |
-
2005
- 2005-11-21 RU RU2007118385/04A patent/RU2007118385A/ru not_active Application Discontinuation
- 2005-11-21 WO PCT/NO2005/000435 patent/WO2006054904A2/en not_active Ceased
- 2005-11-21 EP EP10169506A patent/EP2243496A3/en not_active Withdrawn
- 2005-11-21 US US11/719,662 patent/US8182790B2/en not_active Expired - Fee Related
- 2005-11-21 ES ES05817391T patent/ES2358745T3/es not_active Expired - Lifetime
- 2005-11-21 DE DE602005025911T patent/DE602005025911D1/de not_active Expired - Lifetime
- 2005-11-21 AU AU2005307195A patent/AU2005307195A1/en not_active Abandoned
- 2005-11-21 JP JP2007542955A patent/JP5116480B2/ja not_active Expired - Fee Related
- 2005-11-21 BR BRPI0518328-6A patent/BRPI0518328A2/pt not_active Application Discontinuation
- 2005-11-21 KR KR1020077011496A patent/KR20070091609A/ko not_active Withdrawn
- 2005-11-21 AT AT05817391T patent/ATE494913T1/de not_active IP Right Cessation
- 2005-11-21 EP EP05817391A patent/EP1814598B1/en not_active Expired - Lifetime
- 2005-11-21 CA CA002586621A patent/CA2586621A1/en not_active Abandoned
- 2005-11-21 MX MX2007006050A patent/MX2007006050A/es not_active Application Discontinuation
- 2005-11-21 CN CN2005800470720A patent/CN101107016B/zh not_active Expired - Fee Related
-
2007
- 2007-05-01 IL IL182898A patent/IL182898A0/en unknown
- 2007-06-07 ZA ZA200705043A patent/ZA200705043B/xx unknown
- 2007-06-14 NO NO20073039A patent/NO20073039L/no not_active Application Discontinuation
-
2012
- 2012-06-28 JP JP2012144870A patent/JP2012207027A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX2007006050A (es) | 2007-11-14 |
| NO20073039L (no) | 2007-08-16 |
| CN101107016A (zh) | 2008-01-16 |
| WO2006054904A2 (en) | 2006-05-26 |
| ZA200705043B (en) | 2008-09-25 |
| CA2586621A1 (en) | 2006-05-26 |
| IL182898A0 (en) | 2007-08-19 |
| US20090208412A1 (en) | 2009-08-20 |
| AU2005307195A1 (en) | 2006-05-26 |
| BRPI0518328A2 (pt) | 2008-11-11 |
| WO2006054904A3 (en) | 2007-04-05 |
| JP2012207027A (ja) | 2012-10-25 |
| KR20070091609A (ko) | 2007-09-11 |
| DE602005025911D1 (de) | 2011-02-24 |
| JP2008520658A (ja) | 2008-06-19 |
| ES2358745T3 (es) | 2011-05-13 |
| JP5116480B2 (ja) | 2013-01-09 |
| CN101107016B (zh) | 2011-11-16 |
| ATE494913T1 (de) | 2011-01-15 |
| EP1814598B1 (en) | 2011-01-12 |
| EP2243496A3 (en) | 2012-12-26 |
| EP2243496A2 (en) | 2010-10-27 |
| US8182790B2 (en) | 2012-05-22 |
| EP1814598A2 (en) | 2007-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU710923B2 (en) | Radiolabeled peptides for diagnosis and therapy | |
| RU2007118385A (ru) | Контрастные агенты для направлений доставки во внеклеточный матрикс | |
| CA2452923A1 (en) | Peptide-based compounds for targeting integrin receptors | |
| ES2204954T3 (es) | Formadores de quelatos metalicos que contienen monoamina, diamida y tiol. | |
| ES2274517T3 (es) | Conjugados de peptido-quelato metalico que se unen a la somatostatina. | |
| JPH07506592A (ja) | 造影用のテクネチウム‐９９ｍ標識ペプチド | |
| JP2003531835A5 (OSRAM) | ||
| CA2405469A1 (en) | Integrin binding peptide derivatives | |
| RU2006144279A (ru) | Пептидные соединения | |
| ES2651334T3 (es) | Péptidos marcados con tecnecio | |
| JPH10506880A (ja) | 環状ヘキサペプチド・ソマトスタチン・アナログ | |
| JP2008520658A5 (OSRAM) | ||
| JPH10501236A (ja) | 血栓造影用放射性標識化合物 | |
| US6083480A (en) | Calcitonin receptor binding reagents | |
| Rennen et al. | Scintigraphic imaging of inflammatory processes | |
| RU2013113677A (ru) | Визуализирующие апоптоз агенты на основе лантибиотических пептидов | |
| KR20070034064A (ko) | 개선된 ｎ4 킬레이트제 결합체 | |
| JP2008510679A (ja) | ペプチド系化合物 | |
| RU2010119187A (ru) | Способ визуализации | |
| Masuda et al. | Concise site-specific synthesis of DTPA–peptide conjugates: Application to imaging probes for the chemokine receptor CXCR4 | |
| AU2002301563A1 (en) | Calcitonin Receptor-binding Peptides | |
| MXPA99009549A (en) | Calcitonin receptor-binding peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20090202 |